A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight loss results comparable to those of popular GLP-1 injectables like Ozempic ...

Having made waves the world over, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and ... men who were over 20 years old, were clinically ...

Medicare plans to negotiate prices for Novo Nordisk products Ozempic (an injection to control diabetes), Wegovy (an injection more designed for weight loss), and Rybelsus (a pill for diabetes).

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...

In a fresh appearance on CNBC’s Squawk on the Street, Jim Cramer cautioned viewers to not be caught up by the energy that’s ...

The drug achieved only a 20% weight reduction in study participants, falling short of investor expectations. Novo Nordisk is actively ... rather than in pill form, early results show a 200% ...

Earlier last year, a daily-pill version of Novo's amycretin was shown to lead ... month that Zepbound helped patients lose an average of 20.2% of their weight after 72 weeks, compared to 13.7 ...

The Danish pharmaceutical giant announced Friday that a small clinical trial found that 20 ... the pill could lead to more and faster weight loss than popular weekly injection Wegovy. Novo Nordisk ...